The Akt of translational control

被引:159
作者
Ruggero, D
Sonenberg, N
机构
[1] Fox Chase Canc Ctr, Human Genet Program, Philadelphia, PA 19111 USA
[2] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada
[3] McGill Univ, McGill Canc Ctr, Montreal, PQ H3G 1Y6, Canada
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
Akt; ribosome biogenesis; eIF4E; translation control; cancer;
D O I
10.1038/sj.onc.1209098
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncogene AKT (also called protein kinase B (PKB)) signals to the translational machinery, and activation of protein synthesis by Akt is associated with cancer formation. Akt directly stimulates the activity of translation initiation factors and upregulates ribosome biogenesis. Activation of protein synthesis by Akt is phylogenetically conserved from Drosophila to humans, and is important for regulating cell growth, proliferation and cell survival. Consequently, translation defects due to aberrant Akt activation may be a crucial mechanism leading to tumorigenesis. However, few in vivo studies have established a causative role for aberrant protein synthesis control in cancer. A major challenge in the future will be to identify the specific mRNAs regulated at the level of translation control directly relevant for cellular transformation. In this review, we highlight and discuss the emerging molecular and genetic evidence that support a model by which deregulation of specific or global protein synthesis contributes to cancer.
引用
收藏
页码:7426 / 7434
页数:9
相关论文
共 136 条
[1]   Perturbations of the AKT signaling pathway in human cancer [J].
Altomare, DA ;
Testa, JR .
ONCOGENE, 2005, 24 (50) :7455-7464
[2]   Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells [J].
Avdulov, S ;
Li, S ;
Michalek, V ;
Burrichter, D ;
Peterson, M ;
Perlman, DM ;
Manivel, JC ;
Sonenberg, N ;
Yee, D ;
Bitterman, PB ;
Polunovsky, VA .
CANCER CELL, 2004, 5 (06) :553-563
[3]   Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease [J].
Backman, SA ;
Stambolic, V ;
Suzuki, A ;
Haight, J ;
Elia, A ;
Pretorius, J ;
Tsao, MS ;
Shannon, P ;
Bolon, B ;
Ivy, GO ;
Mak, TW .
NATURE GENETICS, 2001, 29 (04) :396-403
[4]  
Baserga Renato, 2004, VVolume 42, P235
[5]   Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma [J].
Bauer, C ;
Brass, N ;
Diesinger, I ;
Kayser, K ;
Grässer, FA ;
Meese, E .
INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (02) :181-185
[6]   The TOR pathway: A target for cancer therapy [J].
Bjornsti, MA ;
Houghton, PJ .
NATURE REVIEWS CANCER, 2004, 4 (05) :335-348
[7]   Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma [J].
Brass, N ;
Heckel, D ;
Sahin, U ;
Pfreundschuh, M ;
Sybrecht, GW ;
Meese, E .
HUMAN MOLECULAR GENETICS, 1997, 6 (01) :33-39
[8]   CONTROL OF P70 S6 KINASE BY KINASE-ACTIVITY OF FRAP IN-VIVO [J].
BROWN, EJ ;
BEAL, PA ;
KEITH, CT ;
CHEN, J ;
SHIN, TB ;
SCHREIBER, SL .
NATURE, 1995, 377 (6548) :441-446
[9]   Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin [J].
Brunn, GJ ;
Hudson, CC ;
Sekulic, A ;
Williams, JM ;
Hosoi, H ;
Houghton, PJ ;
Lawrence, JC ;
Abraham, RT .
SCIENCE, 1997, 277 (5322) :99-101
[10]   RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 [J].
Burnett, PE ;
Barrow, RK ;
Cohen, NA ;
Snyder, SH ;
Sabatini, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (04) :1432-1437